A fatal hyperpyrexial response to bleomycin following prior therapy: a case report and literature review.
- 1 September 1982
- journal article
- case report
- Vol. 55, 529-31
Abstract
Bleomycin is an effective drug used in the therapy of many malignant diseases. Such toxicities as fever, chills, and pulmonary fibrosis are well known to occur following administration of this drug. A rare fatal hyperpyrexial response has also been noted with this agent. We describe a case of fatal hyperthermia after an injection of bleomycin. Unlike earlier reported cases, our patient developed her reaction following prior uneventful therapy with bleomycin rather than as a response to initial treatment. Factors that may be related to the hyperpyrexial response to bleomycin are discussed and the relevant literature reviewed.This publication has 9 references indexed in Scilit:
- Cytotoxic-induced fulminant hyperpyrexiaCancer, 1980
- Hyperpyrexia, Allergic-Type Response and Death occurring with Low-Dose Bleomycin AdministrationOncology, 1980
- Corticosteroid and Antihistamine Modification of Bleomycin-lnduced FeverExperimental Biology and Medicine, 1979
- Treatment of Advanced Lymphomas with Bleomycin (NSC-125066)Oncology, 1976
- Pyrogenic properties of bleomycin (NSC-125066).1973
- A clinical review of bleomycin—a new antineoplastic agentCancer, 1973
- Bleomycin, an Antitumor AntibioticAnnals of Internal Medicine, 1972
- Treatment of Advanced Malignant Lymphomas With BleomycinBlood, 1972
- Bleomycin therapy in advanced Hodgkin's disease and epidermoid cancersCancer, 1972